The World's First Plant-Based Long-Term Injectable Implant that is Reversible
Cellulora™ is developing a novel cellulose-based material for soft tissue repair. It’s designed to be an injectable, long-term filler with biocompatibility matching autologous tissue.
Cellulora™ was founded to create amazing medical products that help patients look and feel better.
There is a need in medicine for safer, more effective biomaterials for use in tissue reconstruction.
Current injectable implants and fillers are limited in their ability to immediately correct contour defects, as well as in the duration of the effect.
Cellulora's™ product pipeline brings together natural plant-based ingredients and amazing chemistry to produce products that are safe and effective long-term implants.
Cellulora™ is based on methylcellulose, a derivative of the plant polysaccharide cellulose, which is modified to achieve stable material properties that match native soft-tissue, while permitting reversibility. Cellulora's™ two-component methylcellulose-based filler forms a covalently crosslinked hydrogel upon injection.
Methylcellulose is an FDA-approved, biocompatible, plant-based material used for a number of indications ranging from drug delivery to wound healing.
Unlike other natural long-term fillers that are prone to breakdown via enzymes present in the body, methylcellulose cannot be degraded naturally due to a lack of the cellulase enzyme in humans. This creates a stable, low viscosity, volumizing material that can maintain shape and functional properties over a long duration.
Properties such as viscosity and stiffness can be tuned for various applications and anatomical locations.
Overall, long-term stability, immediate tissue bulking effect and selective reversibility are features that distinguish this product from others on the market.
• Made from inexpensive, renewable material (plant cellulose)
• Maintains shape and structural integrity for long time periods
• Provides immediate bulking effect
Interested in learning more?
info@cellulora (dot) com